Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
62.02
+1.09 (1.78%)
At close: Apr 28, 2026, 4:00 PM EDT
62.09
+0.08 (0.12%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Tarsus Pharmaceuticals Market Cap
Tarsus Pharmaceuticals has a market cap or net worth of $2.64 billion as of April 28, 2026. Its market cap has increased by 43.77% in one year.
Market Cap
2.64B
Enterprise Value
2.31B
1-Year Change
43.77%
Ranking
Category
Stock Price
$62.02
Market Cap Chart
Since the IPO on October 16, 2020, Tarsus Pharmaceuticals's market cap has increased from $308.14M to $2.64B, an increase of 756.48%. That is a compound annual growth rate of 47.44%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Relay Therapeutics | 2.83B |
| Soleno Therapeutics | 2.73B |
| Kodiak Sciences | 2.72B |
| Enliven Therapeutics | 2.69B |
| Vera Therapeutics | 2.67B |
| Immunome | 2.66B |
| Celldex Therapeutics | 2.64B |
| Disc Medicine | 2.63B |